GlassScriptPhysician profile
Frank Z Zhao
NPI 1861703779
$13,226.43
in general payments reported to CMS, 2019-2025
13 companies · $733 in 2025
The $733 reported for 2025 was more than what a typical Trauma Surgery provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $364 · 2021: $92.39 · 2022: $162 · 2023: $430 · 2024: $11K · 2025: $733.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,268 · Education: $3,296 · Travel and Lodging: $3,145 · Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,267.50 |
| Education | $3,296.37 |
| Travel and Lodging | $3,145.19 |
| Food and Beverage | $898.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $8,561.34 | 2019-2025 | Advantagerib |
| Intuitive Surgical, INC. | $3,769.94 | 2024-2025 | |
| Kls-Martin L.P. | $242.71 | 2019-2021 | |
| Medtronic, INC. | $156.25 | 2025 | Signia |
| Abbvie INC. | $134.07 | 2022 | |
| Depuy Synthes Sales INC. | $111.97 | 2025 | Matrixrib |
| Atricure, INC. | $66.17 | 2019-2021 | |
| Ethicon US, LLC | $54.06 | 2021-2022 | |
| Pfizer INC. | $53.77 | 2019 | |
| Aroa Biosurgery Incorporated | $24.12 | 2025 | |
| Foundation Medicine, INC. | $19.75 | 2021 | |
| Haemonetics Corporation | $18.00 | 2024 | Teg6s Hemostasis System |
| Convatec INC. | $14.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frank Zhao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.